ISOLATION AND IDENTIFICATION OF STREPTOMYCES BAARNENSIS MH-133 PRODUCE BIOACTIVE METABOLITE INHIBITING MULTIDRUG RESISTANT BACTERIA (MDRB)

Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2017, Vol 3, Issue 6

Abstract

In the present study five agriculture soil samples were collected from Empoli, Tuscany, Italy. Thirty-seven actinomycete isolates were obtained and selected from these samples according to their morphological characteristics and purified on starch nitrate agar medium. These isolates were screened for antibacterial activity against Multidrug Resistant Bacteria (MDRB), (E. faecalis and MRSA) as Gram positive bacteria and (E. coli, Klebsiella pneumonia, Acinetobacter baumanii, Pseudomonus aeruginosa, and Enterobacter cloacae) as Gram negative bacteria in addition to standard strain Bacillus subtilis ATCC-6633, Micrococcus luteus ATCC-4698 and Salmonella typhi ATCC-6539. Among tested actinomycete isolates only MH-133 isolate could inhibit the growth of all tested bacteria except Enterobacter cloacae. Morphological, physiological and biochemical identification results of MH-133 isolate indicated that, it belongs to the genus Streptomyces. The comparative analysis of 16S rDNA sequence and phylogenetic relationship showed that MH-133 isolates lies in a separate clade with Streptomyces baarnensis strain NRRL B-1902. MH-133 isolate was submitted to the GenBank, NCBI under the accession number, KY698030. Factors affecting antibacterial metabolite(s) were optimized to enhance the antibacterial activity. The optimum conditions were pH 8, temperature 30ºC, inoculum size 6% (v/v) on modified marine medium under shaking condition (150 rpm). The fermentation kinetic study was performed and the result showed that the maximum antibacterial activity was significantly achieved at the eighth day while both of carbohydrate consumption and biomass production were not shown significant changes starting from the sixth day. This study clearly proves that our isolate exhibit antibacterial activity against MDRB.

Authors and Affiliations

Dr. Saad A. M. Moghannem

Keywords

Related Articles

A REVIEW ON BODY WEIGHT PERCEPTION AND ITS ASSOCIATED FACTORS AMONG ADOLESCENTS IN MALAYSIA AND WORLDWIDE

Body weight perception differs according to how the individual describe their body figure. Some may underestimate their weight while the other may overestimate it. Wrong body weight perception may lead to various complic...

ANTIBACTERIAL PROPERTIES OF METHANOL AND AQUEOUS EXTRACTS OF ANOGEISSUS LEIOCARPUS AND TERMINALIA MICROPTERA AGAINST SELECTED ORAL PATHOGENS

In Africa, chewing sticks are commonly used for maintaining oral hygiene. Phytochemical contents and antibacterial activity of aqueous and methanol extracts of Terminalia microptera and Anogeissus leiocarpus were investi...

ASYMMETRIC PERIFLEXURAL EXANTHEM OF CHILDHOOD. A CLINICO -EPIDEMIOLOGICAL PROSPECTIVE STUDY OF SEVENTY-FIVE CASES

Introduction: Asymmetric periflexural exanthem of childhood is classified as a rare self-limited and spontaneously resolving exanthem with unknown etiology that occurs mainly in children. Objective: To study the prevalen...

CLINICAL STUDY OF PRATIVISHADI TAIL KARANPURNA AND ASHWAGANDHADYA GHRITA PAANA IN THE MANAGEMENT OF KARAN NAAD W.S.R. TO TINNITUS

Aacharya Sushruta has explained about Karna-Nada & Karna Kshweda. Vitiated Vata Dosha either entering into other channels or encircled by Kaphadi Doshas) in Sabdavaha Srotas produces different types of sounds in the ear...

REVIEW ARTICLE: AYURVEDIC CONCEPTS ON COSMETOLOGY

The word “Cosmetics” means any substance used to clean, improve or change the complexion of skin, hair, nails, teeth or eyes. It includes beauty preparations (perfume, skin cream, nail polish, lipstick or contact lens) a...

Download PDF file
  • EP ID EP655152
  • DOI -
  • Views 183
  • Downloads 0

How To Cite

Dr. Saad A. M. Moghannem (2017). ISOLATION AND IDENTIFICATION OF STREPTOMYCES BAARNENSIS MH-133 PRODUCE BIOACTIVE METABOLITE INHIBITING MULTIDRUG RESISTANT BACTERIA (MDRB). World Journal of Pharmaceutical and Medical Research, 3(6), 64-75. https://europub.co.uk./articles/-A-655152